Claims for Patent: 7,101,993
✉ Email this page to a colleague
Summary for Patent: 7,101,993
Title: | Oligonucleotides containing 2'-O-modified purines |
Abstract: | Compounds are provided containing purine nucleotides that bear moieties X at the 2' position thereof wherein X is R.sub.1--(R.sub.2).sub.n; R.sub.1 is C.sub.3-C.sub.20 alkyl, C.sub.4-C.sub.20 alkenyl or C.sub.2-C.sub.20 alkynyl; R.sub.2 is halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, amino, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, or a group that enhances the pharmacokinetic properties of oligonucleotides; and n is an integer from 0 to about 6. Such compounds are useful for modulating the synthesis of proteins. |
Inventor(s): | Cook; Phillip Dan (San Marcos, CA), McGee; Daniel Peter Claude (Boulder, CA), Guinosso; Charles John (Visia, CA) |
Assignee: | ISIS Pharmaceuticals, Inc. (Carlsbad, CA) |
Application Number: | 07/967,267 |
Patent Claims: |
1. A compound having the structure: ##STR00013## wherein X is R.sub.1--(R.sub.2).sub.n; R.sub.1 is C.sub.2-C.sub.20 alkyl, C.sub.2-C.sub.20 alkenyl, or C.sub.2-C.sub.20
alkynyl and n is 1 to 6; R.sub.2 is halogen, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, imidazole, N-phthalimido, azido, hydrazino,
hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, or polyether; and either one of T.sub.3 and T.sub.5 is OH, a
hydroxyl blocking group, phosphate or an activated phosphate group and the other of T.sub.3 and T.sub.5 is a nucleotide or both T.sub.3 and T.sub.5 are nucleotides.
2. A compound having the structure: ##STR00014## wherein X is R.sub.1--(R.sub.2).sub.n; R.sub.1 is C.sub.1-C.sub.20 alkyl, C.sub.4-C.sub.20 alkenyl, or C.sub.2-C.sub.20 alkynyl; R.sub.2 is halogen, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, imidazole, N-phthalimido, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, or polyether; either one of T.sub.3 and T.sub.5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T.sub.3 and T.sub.5 is a nucleotide, or both T.sub.3 and T.sub.5 are nucleotides; and n is an integer from 1 to 6. 3. The compound of claim 1 wherein R.sub.1 is C.sub.4-C.sub.20 alkyl. 4. The compound of claim 1 wherein R.sub.1 is C.sub.5-C.sub.20 alkyl. 5. The compound of claim 1 wherein R.sub.1 is C.sub.3-C.sub.20 alkyl and n is 1. 6. The compound of claim 1 wherein R.sub.1 is C.sub.4-C.sub.20 alkenyl and n is 1. 7. The compound of claim 1 wherein R.sub.1 is C.sub.2-C.sub.20 alkynyl and n is 1. 8. The compound of claim 1 wherein R.sub.1 is C.sub.2-C.sub.20 alkyl and n is 1 to 6. 9. The compound of claim 1 wherein R.sub.1 is C.sub.2-C.sub.20 alkenyl and n is 1 to 6. 10. The compound of claim wherein R.sub.1 is C.sub.2-C.sub.20 alkynyl and n is 1 to 6. 11. The compound of claim 2 wherein R.sub.1 is C.sub.1-C.sub.20 alkyl. 12. The compound of claim 2 wherein R.sub.1 is C.sub.4-C.sub.20 alkenyl. 13. The compound of claim 2 wherein R.sub.1 is C.sub.2-C.sub.20 alkynyl. ##STR00015## 14. A compound having the structure: wherein X is R.sub.1--(R.sub.2).sub.n; R.sub.1 is C.sub.4-C.sub.20 alkyl, C.sub.4-C.sub.20 alkenyl, or C.sub.2-C.sub.20 alkynyl and n is 0; or R.sub.1 is C.sub.1-C.sub.20 alkyl, C.sub.2-C.sub.20 alkenyl, or C.sub.2-C.sub.20 alkynyl and n is 1 to 6; R.sub.2 is hydroxyl, thiol, keto, carboxyl, or amino; and either one of T.sub.3 and T.sub.5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T.sub.3 and T.sub.5 is a nucleotide or both T.sub.3 and T.sub.5 are nucleotides. 15. A compound having the structure: ##STR00016## wherein X is R.sub.1--(R.sub.2).sub.n; R.sub.1 is C.sub.1-C.sub.20 alkyl, C.sub.4-C.sub.20 alkenyl, or C.sub.2-C.sub.20 alkynyl; R.sub.2 is hydroxyl, thiol, keto, carboxyl, or amino; either one of T.sub.3 and T.sub.5 is OH, a hydroxyl blocking group, phosphate or an activated phosphate group and the other of T.sub.3 and T.sub.5 is a nucleotide, or both T.sub.3 and T.sub.5 are nucleotides; and n is an integer from 0 to 6. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.